Beximco Pharma (BXP.L): Dividend and tax legislation changes affecting Bangladesh companies | Novacyt (NCYT.L): Completion of sale of Clinical Lab for £400k | Motif Bio (MTFB.L): Receipt of Deficiency Notice from Nasdaq
19 Jul 2019
SP Angel Healthcare - Morning Comment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare - Morning Comment
- Published:
19 Jul 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4
Beximco Pharma (BXP.L): Dividend and tax legislation changes affecting Bangladesh companies | Novacyt (NCYT.L): Completion of sale of Clinical Lab for £400k | Motif Bio (MTFB.L): Receipt of Deficiency Notice from Nasdaq